Week beginning 26th October 2026
News, advocacy and articles
USA - CDC A recording of the September 18 ME/CFS SEC Conference Call, including a presentation by Dr. Nancy Klimas, is now available. Call transcript and presentation slides are available on the
CDC website for ME/CFS meetings.
Video |
Thread
UK - The Times I represented Team GB at the Olympics. Now I’m in bed 22 hours a day
Beth Dobbin has written to the prime minister asking for funding for SequenceME and Long Covid, showing how little is spent on ME/CFS research compared with other serious illnesses. “In what other illness would you be sent to a clinic with no doctors? This is a life-debilitating, life-decimating illness. I know people with ME who are tube-fed, who have to be turned. It’s disgraceful not to have anywhere to go on the NHS.”
Article (paywall) |
Thread
Aotearoa / New Zealand Denial of Income Protection Insurance for LC and ME/CFS
"Recent reports of insurance claims being declined on mental health grounds raise questions about how insurers assess this disabling physical illness." "Long Covid Support Aotearoa is calling for an investigation into the use of mental health exclusions in Long Covid insurance claims."
Radio New Zealand |
The Post |
Long Covid Support Aotearoa |
Thread
Bateman Horne Center When the Seasons Change: Seasonal Transition as an Exertional Stressor
Blog post about people with ME/CFS and Long Covid who experience a downturn when the season changes.
Article |
Thread
USA - Solve M.E. 2026 State of the Union: From Protecting Progress to Building What’s Next
A US based advocacy campaign called "The Long Game: Building Political Power As a Community" was discussed in their
October 20 Community Address. To get involved sign up for one or more of the nine training sessions that are scheduled between January and April.
Article |
Thread
Trial by Error by David Tuller Some Recent Observations from Alem Matthees
Tuller shares from communication with Alem Matthees, who in 2016 managed to get data from the PACE trial released. He deteriorated dramatically afterwards and is sharing observations and experiences from an existence with very severe ME.
Article l
Thread
........
Coming events
Bateman Horne Center Free Online Support Group
Tuesday, November 17, 1 - 2 pm MDT
Topic:
Gratitude as a Happiness and Resilience Skill ...
Advance registration required, registration link shows time in your time zone.
Registration |
Thread
.......
Research news and commentary
RME Conference Videos from the "Bridging immunology and genetics in ME/CFS and Long Covid" conference, organised by the Swedish patient organisation RME, are now up with lectures from Jonas Bergquist, David Systrom, Walles/Hejazi, Serena Fineschi, Carmen Scheibenbogen, Maria Lerm, Chris Ponting and Enander/Hempel Svenonius as well as a panel discussion.
Videos l
Thread
USA - NIH RECOVER Biosamples from RECOVER’s youngest participants can unlock discoveries about pediatric Long COVID
Discussion of the collection of biosamples from children, teens, and young adults who have Long Covid and how these samples can be used in future research.
Article |
Thread
.......
Research
ME/CFS research
Stress-inducible WASF3 regulates brain metabolism and cognitive function — Syed et al
"we investigated the role of WASF3 in brain metabolism and function using WASF3 transgenic and knockout mouse models." "findings demonstrate that WASF3 suppresses oxidative metabolism in the brain and contributes to cognitive dysfunction"
Article |
Thread
Treg and Oxidative Stress Biomarker Profiles in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome — Todorova et al
"Altered T-cell subsets were strongly associated with markers of oxidative (GPX1) and nitrosative (NOS3) stress but not directly with symptom severity."
Article |
Thread
mTORC1 dysregulation and context-dependent mitochondrial dysfunction in ME/CFS: a mechanistic and translational review — Sunseri et al
"This review evaluates the mechanistic target of rapamycin complex 1 (mTORC1) as a dynamic control point that may link mitochondrial signaling, immunometabolism, inflammation, autophagy, and the post-exertional response."
Article |
Thread
Long Covid research
Low Dose Naltrexone for Post-COVID Fatigue Syndrome: A Randomized Controlled Trial — Naik et al
"Compared to placebo, LDN at doses up to 4.5 mg/day for 16 weeks was well tolerated but did not improve fatigue severity in people with PCFS." "our results contrast with suggested benefits of LDN in open uncontrolled studies in Long COVID or ME/CFS"
Preprint |
Thread
Metformin at the Time of COVID-19 Infection and Risk of Long COVID: A Target Trial Emulation Study — Bramante et al
"Metformin prescription within the week following documented SARS‐CoV‐2 infection was associated with a 53% reduction in [Long Covid or death] over 6 months in this primarily Omicron‐infected sample."
Article |
Thread
Real-world effectiveness of Paxlovid in protecting Long COVID for outpatient adult patients: A target trial emulation study from the RECOVER Initiative — Zang et al
"High-risk, nonhospitalized adult patients with COVID-19 who were treated with Paxlovid within 5 days of SARS-CoV-2 infection had a lower risk of Long COVID and all-cause hospitalization or death in the post-acute period." "However, Long COVID risk reduction with Paxlovid was not observed in low-risk patients."
Article |
Thread
Strong Protein Responses to Acute Infection Control General Post-Viral Sequelae and SARS-CoV-2-specific Neurocognitive Sequelae — Liou et al
"ADAR stood out in our results, because it had the strongest protective incidence ratio against Neurocognitive Sequelae for patients with SARS-CoV-2 infection and the greatest beneficial incidence ratio against General Sequelae for all patients."
Preprint |
Thread
Associations between salivary HHV-6 and long COVID severity in a cross-sectional, case–control analysis — Laxton et al
"whether HHV-6 reactivation is a response to, or a trigger of, increased symptom severity remains to be investigated."
Article |
Thread
Multifactorial biomarker profiles in fatigued and non-fatigued post-COVID-19 patients: insights from a one-year follow-up — Barrero-Santiago et al
"Fatigue was associated with variants in COMT, NR3C1, and MMP9, alongside biochemical, inflammatory, and muscle-related alterations" "A notable finding was the significant group × assessment interaction for vastus lateralis thickness, whereas no interaction was observed for rectus femoris, vastus medialis, knee extensor torque, or CPK."
Article |
Thread
...........
S4ME social media:
Forum,
Mastodon,
Bluesky